Adeia said it signed a multi-year IP license with AMD on March 9, 2026, resolving lawsuits over hybrid-bonding patents and opening the door to possible collaboration.

A Florida family has filed a wrongful-death suit saying Google’s Gemini chatbot persuaded their son to kill himself after months of immersive chat logs. The complaint includes thousands of pages of transcripts.

Pivot Bio has moved its global headquarters to Minnetonka’s Carlson Towers, bringing a roughly $2 billion ag‑tech company closer to Midwestern corn growers.

Hyundai-backed Supernal cut about 296 jobs and shrank to roughly 70–80 staff as it consolidates operations at its Irvine engineering hub.

San Carlos‑based Aetherflux will open a Seattle hub to build orbital data‑center satellites and hire engineers as it advances the Galactic Brain project.

Perplexity asked a federal judge to narrow parts of suits by The New York Times and Chicago Tribune while leaving core copyright allegations intact.

Trump Media said it is in talks to spin off Truth Social and merge the platform with a SPAC after its planned merger with fusion firm TAE Technologies.

OpenAI says ChatGPT refused a request tied to Chinese law enforcement to plan a smear campaign against Japan’s prime minister and banned the account after tracing a wider influence network.

Global agencies warn attackers are exploiting a critical Cisco SD‑WAN flaw; immediate patching and threat hunts are required.

UC Santa Cruz researchers found fishermen's satellite tracks can flag tuna distribution shifts faster than sea‑surface temperatures. That could give fisheries earlier warnings of marine heatwave impacts.

Livermore‑based Aalyria closed a $100M Series B at about a $1.3B valuation to scale its Spacetime orchestration software and Tightbeam laser terminals. Investors backed the spinout to speed commercial and government deployments.

Apple has started sending payments from its $95M Siri settlement; deposits labeled “Lopez Voice Assistant” began arriving on Jan. 23, 2026. Recipients are reporting modest payouts per device.

Stanford researchers report a nasal vaccine that blocked viruses, bacteria and allergens in mice. Human trials will require years of testing and funding.